Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trane Technologies
TT
|
+$169M |
| 2 |
AbbVie
ABBV
|
+$155M |
| 3 |
Otis Worldwide
OTIS
|
+$127M |
| 4 |
Blackrock
BLK
|
+$110M |
| 5 |
Alibaba
BABA
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$372M |
| 2 |
RTN
Raytheon Company
RTN
|
+$235M |
| 3 |
Apple
AAPL
|
+$143M |
| 4 |
Microsoft
MSFT
|
+$90.5M |
| 5 |
McDonald's
MCD
|
+$56.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.87% |
| 2 | Healthcare | 13.29% |
| 3 | Financials | 12.68% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
2201
DELISTED
Radius Health, Inc.
RDUS
| $433K | ﹤0.01% |
31,830
+99
| +0.3% | +$1.36K |
|
2202
Baytex Energy
BTE
$2.92B
| $429K | ﹤0.01% |
846,746
+3,893
| +0.5% | +$1.4K |
|
2203
Weis Markets
WMK
$1.86B
| $429K | ﹤0.01% |
8,547
-634
| -7% | -$31.8K |
|
2204
Newmark Group
NMRK
$2.63B
| $427K | ﹤0.01% |
87,785
-3,764
| -4% | -$15.8K |
|
2205
1st Source
SRCE
$2.12B
| $426K | ﹤0.01% |
11,965
+343
| +3% | +$11.4K |
|
2206
Stock Yards Bancorp
SYBT
$2.6B
| $424K | ﹤0.01% |
10,542
+68
| +0.6% | +$2.22K |
|
2207
Dillards
DDS
$9.56B
| $420K | ﹤0.01% |
16,313
-9,955
| -38% | -$281K |
|
2208
Karyopharm Therapeutics
KPTI
$48M
| $420K | ﹤0.01% |
1,479
+598
| +68% | +$177K |
|
2209
Metallus
MTUS
$898M
| $420K | ﹤0.01% |
108,013
+6,480
| +6% | +$21.7K |
|
2210
BancFirst
BANF
$3.8B
| $419K | ﹤0.01% |
10,349
| – | – |
|
|
GHL
2211
DELISTED
Greenhill & Co., Inc.
GHL
| $416K | ﹤0.01% |
41,613
+2,434
| +6% | +$24K |
|
2212
Amneal Pharmaceuticals
AMRX
$5.79B
| $415K | ﹤0.01% |
87,139
-2,181
| -2% | -$8.98K |
|
2213
Virgin Galactic
SPCE
$398M
| $410K | ﹤0.01% |
+1,255
| New | +$412K |
|
|
ATNX
2214
DELISTED
Athenex, Inc. Common Stock
ATNX
| $409K | ﹤0.01% |
1,485
+59
| +4% | +$12.5K |
|
|
TBIO
2215
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $408K | ﹤0.01% |
22,751
+4,404
| +24% | +$66.4K |
|
|
ADVM
2216
DELISTED
Adverum Biotechnologies
ADVM
| $407K | ﹤0.01% |
1,949
+718
| +58% | +$127K |
|
|
ARD
2217
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $407K | ﹤0.01% |
31,479
| – | – |
|
|
CWEN.A
2218
DELISTED
Clearway Energy Class A
CWEN.A
| $406K | ﹤0.01% |
19,393
-5,349
| -22% | -$104K |
|
2219
Twist Bioscience
TWST
$7.25B
| $399K | ﹤0.01% |
8,814
+3,503
| +66% | +$126K |
|
2220
Kearny Financial
KRNY
$599M
| $395K | ﹤0.01% |
48,245
-131
| -0.3% | -$1.1K |
|
2221
Chesapeake Utilities
CPK
$3.21B
| $394K | ﹤0.01% |
4,696
+73
| +2% | +$6.34K |
|
|
ANAT
2222
DELISTED
American National Group, Inc. Common Stock
ANAT
| $393K | ﹤0.01% |
5,444
-7
| -0.1% | -$523 |
|
2223
Columbia Financial
CLBK
$1.13B
| $388K | ﹤0.01% |
27,833
+5,230
| +23% | +$73.1K |
|
2224
Rayonier Advanced Materials
RYAM
$610M
| $387K | ﹤0.01% |
138,380
+3,730
| +3% | +$7.15K |
|
|
DNR
2225
DELISTED
Denbury Resources, Inc.
DNR
| $387K | ﹤0.01% |
1,398,577
+46,649
| +3% | +$14K |
|
Similar funds
Legal & General Group's Q2 2020 Portfolio in Review
As of Q2 2020, Legal & General Group held 3,579 positions worth $207B, up 21% from $171B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Legal & General Group's Q2 2020 filing shows 222 new, 1,974 increased, 815 reduced and 175 closed positions. Its largest new stake was Otis Worldwide: 2,441,915 shares worth $139M. The largest sale was Allergan plc, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Legal & General Group's largest Q2 2020 buy was Otis Worldwide: 2,441,915 shares worth $139M.
- Legal & General Group added most to Trane Technologies in Q2 2020, an estimated $169M increase.
- Legal & General Group's biggest Q2 2020 reduction was Apple, cutting an estimated $143M.
- Legal & General Group fully exited Allergan plc in Q2 2020, selling an estimated $372M.
- Legal & General Group's ten largest holdings make up 21% of its $207B portfolio in Q2 2020.
- Legal & General Group opened 222 new positions and closed 175 in Q2 2020.
- Legal & General Group's portfolio value rose 21% quarter-over-quarter to $207B.
Based on Legal & General Group's 13F filing for Q2 2020, filed 14 Aug 2020.